Report

Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies

+ See all authors and affiliations

Science  19 Aug 2011:
Vol. 333, Issue 6045, pp. 1030-1034
DOI: 10.1126/science.1206954

Log in to view full text


Subjects

Navigate This Article